Clinical Trial Update: Hyperkalaemia and Its Impact on Therapy with RAASi

View source ↗

Summary

A completed clinical trial evaluated how hyperkalemia impacts the continuation or dosing of renin-angiotensin-aldosterone system inhibitors in patients with hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• RAAS inhibitors (Renin-angiotensin-aldosterone system inhibitors)

Snippet

Sponsor: Portsmouth Hospitals NHS Trust | Conditions: Hyperkalaemia, Heart Failure with Reduced Ejection Fraction | Status: COMPLETED